Moreover, KEGG pathway analysis indicated the PI3K/AKT signaling pathway may play an important role in BYD’s mechanism of action, which are closely associated to the secretion of various (anti-)inflammatory cytokines, oxidative stress status, and immunoregulation in asthma, which strongly support the notion that the PI3K/AKT signaling pathway may hold significant relevance in BYD treatment for asthma. The gene discussed is AKT1; the disease is asthma.